1. Home
  2. LUCD vs SRBK Comparison

LUCD vs SRBK Comparison

Compare LUCD & SRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUCD
  • SRBK
  • Stock Information
  • Founded
  • LUCD 2018
  • SRBK 1887
  • Country
  • LUCD United States
  • SRBK United States
  • Employees
  • LUCD 70
  • SRBK N/A
  • Industry
  • LUCD Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • SRBK
  • Sector
  • LUCD Health Care
  • SRBK
  • Exchange
  • LUCD Nasdaq
  • SRBK Nasdaq
  • Market Cap
  • LUCD 108.0M
  • SRBK 117.4M
  • IPO Year
  • LUCD 2021
  • SRBK N/A
  • Fundamental
  • Price
  • LUCD $1.07
  • SRBK $14.67
  • Analyst Decision
  • LUCD Strong Buy
  • SRBK
  • Analyst Count
  • LUCD 5
  • SRBK 0
  • Target Price
  • LUCD $3.65
  • SRBK N/A
  • AVG Volume (30 Days)
  • LUCD 1.6M
  • SRBK 30.6K
  • Earning Date
  • LUCD 11-12-2025
  • SRBK 10-25-2025
  • Dividend Yield
  • LUCD N/A
  • SRBK 1.35%
  • EPS Growth
  • LUCD N/A
  • SRBK N/A
  • EPS
  • LUCD N/A
  • SRBK 0.44
  • Revenue
  • LUCD $4,360,000.00
  • SRBK $31,833,000.00
  • Revenue This Year
  • LUCD $22.80
  • SRBK N/A
  • Revenue Next Year
  • LUCD $221.19
  • SRBK N/A
  • P/E Ratio
  • LUCD N/A
  • SRBK $33.89
  • Revenue Growth
  • LUCD 14.74
  • SRBK 39.53
  • 52 Week Low
  • LUCD $0.73
  • SRBK $10.25
  • 52 Week High
  • LUCD $1.80
  • SRBK $15.22
  • Technical
  • Relative Strength Index (RSI)
  • LUCD 50.26
  • SRBK 47.87
  • Support Level
  • LUCD N/A
  • SRBK $14.82
  • Resistance Level
  • LUCD $1.09
  • SRBK $15.11
  • Average True Range (ATR)
  • LUCD 0.09
  • SRBK 0.17
  • MACD
  • LUCD -0.06
  • SRBK -0.06
  • Stochastic Oscillator
  • LUCD 69.53
  • SRBK 0.00

About LUCD Lucid Diagnostics Inc.

Lucid Diagnostics Inc is a commercial-stage medical diagnostics technology company focused on the millions of patients with gastroesophageal reflux disease (GERD), also known as chronic heartburn, acid reflux, or simply reflux, who are at risk of developing esophageal precancer and cancer, specifically lethal esophageal adenocarcinoma. Its products include EsoCheck and EsoGuard.

About SRBK SR Bancorp Inc. Common stock

SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.

Share on Social Networks: